Почетна › Рак на простата › Северна Каролина › Durham
Клинички испитувања за Рак на простата во Durham, NC
32 студии за Рак на простата бараат учесници на локации во и околу Durham (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
The Vanguard Study: Testing a New Way to Screen for Cancer
Се регрутираДобредојдени се здрави волонтери
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · на 10 милји
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Се регрутираФаза 1/2
- Duke University, Durham
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Се регрутираФаза 3
- Durham VA Medical Center, Durham
- Duke University Medical Center, Durham
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Се регрутираФаза 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · на 10 милји
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- Durham VA Medical Center, Durham
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Се регрутираФаза 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · на 10 милји
DESTINY-PANTUMOUR04
Се регрутираНабљудувачка студија
- Research Site, Durham
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Се регрутираФаза 1/2
- Duke University Medical Center, Durham
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Се регрутираФаза 3
- Duke University Medical Center (location of scans), Durham
- Duke University Medical Center - Duke Cancer Center, Durham
- Duke University Medical Center - Duke University Hospital (location of scans), Durham
- и уште 1
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Се регрутираФаза 2
- Durham VA Medical Center, Durham, NC, Durham
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Се регрутираФаза 2
- Durham VA Medical Center, Durham, NC, Durham
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Се регрутираФаза 1
- Duke University Medical Center, Durham
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Се регрутираФаза 3
- Duke University Medical Center, Durham
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Се регрутираФаза 3
- Durham VA Medical Center, Durham
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
Се регрутираНабљудувачка студија
- Duke University, Durham
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Се регрутираФаза 1
- Duke University Medical Center, Durham
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Се регрутираФаза 1/2
- Duke University medical center, Durham
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Се регрутираФаза 1/2
- Duke University, Durham
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Се регрутираФаза 2
- Duke University Medical Center - Duke Cancer Center, Durham
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Се регрутираФаза 1
- Duke Cancer Institute, Durham
Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer
Се регрутираНабљудувачка студија
- Duke University, Durham
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Се регрутираФаза 1
- Duke Cancer Center, Durham
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Се регрутираФаза 1/2
- Duke University, Durham
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
Се регрутираДобредојдени се здрави волонтери
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · на 10 милји
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Се регрутираФаза 4
- Duke University Medical Center, Durham
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Се регрутираНабљудувачка студија
- Durham VA Medical Center, Durham
- Duke Cancer Network, Durham
- Duke University, Durham
- и уште 1
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Се регрутираФаза 2/3
- Durham VA Medical Center, Durham, NC, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Се регрутираФаза 1
- Duke Cancer Institute, Durham
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Се регрутираФаза 1
- Duke Cancer Center, Durham
Designing Visual Tools to Enhance Cancer Surgeon Decision-making
Се регрутира
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · на 10 милји
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Се регрутираНабљудувачка студија
- Massive Bio SYNERGY-AI site, Chapel Hill · на 10 милји
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
Се регрутираНабљудувачка студија
- Duke University Medical Center, Durham
Испитувања за Рак на простата во други градови
- New York City, NY103 студии
- Houston, TX76 студии
- Los Angeles, CA61 студија
- Boston, MA59 студии
- St. Louis, MO46 студии
- Chicago, IL45 студии
- San Francisco, CA45 студии
- Philadelphia, PA44 студии
- Baltimore, MD43 студии
- Nashville, TN43 студии
- Seattle, WA42 студии
- Washington, DC38 студии
Други студии во Durham
- Рак на дојка64 студии
- Рак (сите типови)58 студии
- Рак на бели дробови со не-мали клетки39 студии
- Множен миелом37 студии
- Акутна миелоидна леукемија33 студии
- Метастатски карцином33 студии
- Рак на бели дробови32 студии
- Колоректален карцином28 студии
- Карцином на јајниците27 студии
- Хронична лимфоцитна леукемија27 студии
- Срцева слабост26 студии
- Карцином на панкреасот24 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.